Provided by Tiger Trade Technology Pte. Ltd.

Arcus Biosciences Inc.

29.85
+0.14000.47%
Post-market: 29.850.00000.00%19:30 EDT
Volume:1.23M
Turnover:36.71M
Market Cap:3.80B
PE:-7.73
High:31.47
Open:30.17
Low:29.32
Close:29.71
52wk High:31.74
52wk Low:10.55
Shares:127.33M
Float Shares:89.84M
Volume Ratio:1.18
T/O Rate:1.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8641
EPS(LYR):-3.2900
ROE:-90.82%
ROA:-30.39%
PB:8.19
PE(LYR):-9.07

Loading ...

U.S. RESEARCH ROUNDUP-CNX Resources, P&G, Prologis

Reuters
·
Apr 21

Arcus Biosciences Discontinues Lung Cancer Trial With Gilead

Dow Jones
·
Apr 20

BRIEF-Arcus Biosciences Inc - Discontinues Phase 3 Star-121 Study With Gilead Due To Futility

Reuters
·
Apr 20

Arcus Biosciences Inc - Gilead's Option Rights Under Collaboration Agreement to End July 14, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 20

Arcus Biosciences Inc - Discontinues Phase 3 Star-121 Study With Gilead Due to Futility - SEC Filing

THOMSON REUTERS
·
Apr 20

Arcus Biosciences discontinues Phase 3 STAR-121 lung cancer trial for futility

Reuters
·
Apr 20

Arcus Biosciences grants new employee stock options for 7,850 shares under inducement plan

Reuters
·
Apr 10

Wedbush raises Arcus Biosciences price target to $41, adds to Best Ideas List

TIPRANKS
·
Apr 02

Arcus Biosciences Is Maintained at Outperform by Wedbush

Dow Jones
·
Apr 02

Arcus Biosciences Inc : Wedbush Raises Target Price to $41 From $37

THOMSON REUTERS
·
Apr 02

Wedbush Raises Price Target on Arcus Biosciences to $41 From $37, Keeps Outperform Rating, Adds Stock to Best Ideas List

MT Newswires Live
·
Apr 02

Assessing Arcus Biosciences (RCUS) Valuation After Recent Share Price Weakness And Strong One Year Rebound

Simply Wall St.
·
Mar 28

Arcus Biosciences grants new hires stock options for 7,050 shares at $21.41 per share

Reuters
·
Mar 25

Mizuho Securities Remains a Buy on Arcus Biosciences (RCUS)

TIPRANKS
·
Mar 24

Arcus Biosciences COO Jennifer Jarrett to resign March 30, 2026

Reuters
·
Mar 23

Arcus Biosciences grants new-hire equity awards for 25,600 shares under 2020 Inducement Plan

Reuters
·
Mar 10

Arcus Biosciences Is Maintained at Buy by Citigroup

Dow Jones
·
Mar 06

Arcus Biosciences price target raised to $45 from $44 at Citi

TIPRANKS
·
Mar 05

Evercore ISI Sticks to Their Buy Rating for Arcus Biosciences (RCUS)

TIPRANKS
·
Mar 03

Arcus Biosciences Up Over 19%, on Pace for Largest Percent Increase Since February 2024 -- Data Talk

Dow Jones
·
Mar 03